The inaugural Duke Cardiovascular Research Center (CVRC) Research Staff Appreciation Award was presented to William Darrell Capel earlier this week. Capel was nominated by his direct supervisor, Robert Lefkowitz, MD, and was recognized for his service as a mentor and teacher in the lab.
In clinic, cardiologist Sudarshan Rajagopal, MD, PhD, has no means to cure most patients with pulmonary hypertension, not the narrowing of blood vessels in their lungs, not damage done to their hearts.
The physician-scientist can prescribe medicines that extend the lives of many patients, but the precious gains can come with unwelcome costs.
“All these drugs help open blood vessels in the lungs and help treat heart failure. But they can have horrible side effects,” Rajagopal says, including nausea, diarrhea, weight loss and other side effects.
But help may come from complex pharmacology studies that Rajagopal first encountered at Duke in the laboratory of Nobel Prize winner Robert Lefkowitz, MD.
Nobel Prize-winning biochemist Robert J. Lefkowitz, MD, had trouble hearing questions in large lecture halls -- until he tried today’s hearing aids.
Robert J. Lefkowitz, MD, will present his research at the Department's Research Seminar Series at noon on Friday, Jan. 27, 2017 in Duke Hospital Room 2002. Dr. Lefkowitz will discuss G-Protein Coupled Receptors.
Robert Lefkowitz, MD, and Howard Rockman, MD, are colleagues and collaborators. They recently sat down to talk about what they've learned in their long careers in biomedical research. Hear more from Dr. Lefkowitz at noon on Fri., Jan. 27, at Medicine Research Seminar.
Mark your calendar: Three events held at Duke University this year will honor Robert J. Lefkowitz, MD, professor of medicine (Cardiology) and 2012 Nobel Laureate in Chemistry.
If you haven't seen a Nobel Prize in person, here is your chance: Robert Lefkowitz's 2012 Nobel Prize for Chemistry is on display on the ground flo